Motility and Metabolic Pharmacoepidemiology Group, Ma KS, et al
The research team hopes their findings will encourage clinicians and regulators to pay closer attention to patient-reported experiences shared online
Wharton, S., Blevins, T., Connery, L., Rosenstock, J., Raha, S., Liu, R., Ma, X., Mather, K
A new study is investigating whether higher doses of injectable GLP-1 agonist Trulicity (dulaglutide) are more effective
These experiments help clarify how integrated incretin and glucagon signaling affects the relationship between intake-side regulation and expenditure-side regulation in complex biological systems [1][5]
Allergic skin reactions require more careful attention